在高血压患者的诱导过程中,西普罗对血液动力学的影响:一项前性,随机化,双盲,受控研究
Hongyi Xiao1, Mingxin Ji2, Xinyuan Shi3
1Department of Anesthesiology, Weifang People's Hospital, Weifang, 261041, People's Republic of China.
Drug design, development and therapy
|December 22, 2025
概括
与在接受妇科手术的高血压患者中用于麻醉诱导的propofol相比,西普罗提供了优越的血液动力稳定性. 这导致降低低血压和改善患者的治疗结果.
科学领域:
- 麻醉学 麻醉学
- 心血管药理学心血管药理学
- 妇科外科手术 妇科外科
背景情况:
- 接受手术的高血压患者有增加的诱导后低血压的风险.
- 普罗波是一种常见的麻醉诱导剂,但可以引起显著的低血压.
- 西普罗是一种较新的麻醉剂,具有不同的药理动力学特征.
研究的目的:
- 为了比较西普罗与普罗波对诱导后低血压的影响.
- 在接受妇科手术的高血压患者的麻醉诱导期间评估血液动力学稳定性.
主要方法:
- 96名接受妇科日间手术的高血压患者随机分配给接受西普罗福尔 (0.5毫克/公斤) 或普罗波福尔 (2毫克/公斤) 进行麻醉诱导.
- 主要结局包括诱导期间低血压的发病率和曲线下的面积 (AUC).
- 二次结局评估了平均动脉压 (MAP) 的变化,血管压缩剂的使用,失去意识的时间,BIS值,恢复时间,注射疼痛以及术后恶心和吐 (PONV).
主要成果:
- 与propofol相比,西普罗显著降低了低血压的发生率 (66.7%与89.6%) 和低血压的AUC.
- 西普罗表现出更好的血液动力学稳定性,MAP波动不那么明显,血管压缩剂需求减少.
- 西普罗也导致注射疼痛的发生率明显降低,尽管恢复时间略有延长. 没有观察到PONV的差异.
结论:
- 与propofol相比,西普罗在高血压患者的麻醉诱导过程中提供了卓越的血液动力稳定性.
- 在这种患者群体中,西普罗可能是麻醉诱导的更安全的替代品,减少低血压和相关并发症的风险.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
415
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
415
Hypertension III: Clinical Manifestations and Diagnostic Studies
442
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
442
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
331
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
331
Cardiac Catheterization I: Pre-Procedure Overview
993
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
993
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
879
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
879
Pre-Procedural Guidelines for Assessing Blood Pressure
790
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
790


